Auditing reforested watersheds on the loess plateau: Fangshan ShanxiHAIKAI TANE; TUOHUAN SUN; ZHILI ZHENG et al.Ecological indicators. 2014, Vol 41, pp 96-108, issn 1470-160X, 13 p.Article

Oxidative damage by phenylhydrazine diminishes erythrocyte anion transportPETTY, H. R; MING-JIE ZHOU; ZHILI ZHENG et al.Biochimica et biophysica acta. Biomembranes. 1991, Vol 1064, Num 2, pp 308-314, issn 0005-2736, 7 p.Article

Proteinase K decreases Pseudomonas aeruginosa adhesion to wounded corneaHAZLETT, L. D; MASINICK, S; BERK, R. S et al.Experimental eye research. 1992, Vol 55, Num 4, pp 579-587, issn 0014-4835Article

Q vectors, bicistronic retroviral vectors for gene transferJULIUS, M. A; QINGYOU YAN; ZHILI ZHENG et al.BioTechniques. 2000, Vol 28, Num 4, pp 702-708, issn 0736-6205, 6 p.Article

Corneal epithelial glycoproteins exhibit Pseudomonas aeruginosa pilus binding activityRUDNER, X. L; ZHILI ZHENG; BERK, R. S et al.Investigative ophthalmology & visual science. 1992, Vol 33, Num 7, pp 2185-2193, issn 0146-0404Article

Lack of specific γ-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulationBURNS, William R; ZHILI ZHENG; ROSENBERG, Steven A et al.Blood. 2009, Vol 114, Num 14, pp 2888-2899, issn 0006-4971, 12 p.Article

Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stabilityCOHEN, Cyrille J; YANGBING ZHAO; ZHILI ZHENG et al.Cancer research (Baltimore). 2006, Vol 66, Num 17, pp 8878-8886, issn 0008-5472, 9 p.Article

Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma ImmunotherapyBEARD, Rachel E; ABATE-DAGA, Daniel; ROSATI, Shannon F et al.Clinical cancer research (Print). 2013, Vol 19, Num 18, pp 4941-4950, issn 1078-0432, 10 p.Article

Development of Human Anti-Murine T-Cell Receptor Antibodies in Both Responding and Nonresponding Patients Enrolled in TCR Gene Therapy TrialsDAVIS, Jeremy L; THEORET, Marc R; ZHILI ZHENG et al.Clinical cancer research (Print). 2010, Vol 16, Num 23, pp 5852-5861, issn 1078-0432, 10 p.Article

Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functionsHUGHES, Marybeth S; YU, Yik Y. L; MORGAN, Richard A et al.Human gene therapy. 2005, Vol 16, Num 4, pp 457-472, issn 1043-0342, 16 p.Article

Adoptive Cell Therapy for Patients with Melanoma, Using Tumor-Infiltrating Lymphocytes Genetically Engineered to Secrete Interleukin-2HEEMSKERK, Bianca; KE LIU; MORGAN, Richard A et al.Human gene therapy. 2008, Vol 19, Num 5, pp 496-510, issn 1043-0342, 15 p.Article

Cancer regression in patients after transfer of genetically engineered lymphocytesMORGAN, Richard A; DUDLEY, Mark E; ZHILI ZHENG et al.Science (Washington, D.C.). 2006, Vol 314, Num 5796, pp 126-129, issn 0036-8075, 4 p.Article

Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individualsMORGAN, Richard A; WALKER, Robert; BUNNELL, Bruce A et al.Human gene therapy. 2005, Vol 16, Num 9, pp 1065-1074, issn 1043-0342, 10 p.Article

Lentiviral Vector Design for Optimal T Cell Receptor Gene Expression in the Transduction of Peripheral Blood Lymphocytes and Tumor-Infiltrating LymphocytesJONES, Stephanie; PENG, Peter D; SHICHENG YANG et al.Human gene therapy. 2009, Vol 20, Num 6, pp 630-640, issn 1043-0342, 11 p.Article

Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expressionWARGO, Jennifer A; ROBBINS, Paul F; ROSENBERG, Steven A et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 3, pp 383-394, issn 0340-7004, 12 p.Article

Cytokine-independent growth and clonal expansion of a primary human CD8⁺ T-cell clone following retroviral transduction with the IL-15 geneHSU, Cary; JONES, Stephanie A; DUNBAR, Cynthia E et al.Blood. 2007, Vol 109, Num 12, pp 5168-5177, issn 0006-4971, 10 p.Article

Evaluation of γ-Retroviral Vectors That Mediate the Inducible Expression of IL-12 for Clinical ApplicationLING ZHANG; FELDMAN, Steven A; ZHILI ZHENG et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 5, pp 430-439, issn 1524-9557, 10 p.Article

Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for GliomaMORGAN, Richard A; JOHNSON, Laura A; WEI ZHANG et al.Human gene therapy. 2012, Vol 23, Num 10, pp 1043-1053, issn 1043-0342, 11 p.Article

Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansionGOFF, Stephanie L; JOHNSON, Laura A; BLACK, Mary A et al.Cancer immunology and immunotherapy. 2010, Vol 59, Num 10, pp 1551-1560, issn 0340-7004, 10 p.Article

Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via notch signalingYANGBING ZHAO; PARKHURST, Maria R; ZHILI ZHENG et al.Cancer research (Baltimore). 2007, Vol 67, Num 6, pp 2425-2429, issn 0008-5472, 5 p.Article